FDA Inspection 1322010 — Neetu Talreja, M.D.
The FDA completed an inspection of Neetu Talreja, M.D. on May 22, 2026 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 22, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boise, ID (United States)
Additional Details
Clinical Investigator (CI)